Cellebrite officer files Form 3 with no trades

Cellebrite DI Ltd. submitted a Form 3 identifying Ramji Shiven as an officer with the title President Products & Tech.

Rhea-AI Filing Summary

Cellebrite DI Ltd. submitted a Form 3 identifying Ramji Shiven as an officer with the title President Products & Tech. The filing does not report any share purchases, sales, or other transactions, and shows no derivative positions or holdings data in the provided summary.

Key Terms

Form 3, transactionSummary, derivativeSummary

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3): {"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

transactionSummary financial

""transactionSummary": { "buyCount": 0, "sellCount": 0,"

derivativeSummary financial

""derivativeSummary": [],"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Cellebrite (CLBT) Form 3 filing for Ramji Shiven show?

The Form 3 filing identifies Ramji Shiven as an officer of Cellebrite DI Ltd. with the title President Products & Tech. It reports no share purchases, sales, or derivative transactions in the provided transaction summary.

Does the Cellebrite (CLBT) Form 3 for Ramji Shiven report any stock trades?

No, the Form 3 for Ramji Shiven shows zero buy, sell, gift, exercise, tax withholding, or restructuring transactions. The transaction summary lists all transaction counts and related share amounts as zero.

What is Ramji Shiven’s role at Cellebrite (CLBT) according to this Form 3?

According to the filing, Ramji Shiven is an officer of Cellebrite DI Ltd. with the title President Products & Tech. He is not listed as a director or ten percent owner in the provided data.

Does the Cellebrite (CLBT) Form 3 show any derivative positions for Ramji Shiven?

No, the derivative summary in the Form 3 is empty. This indicates no listed options, warrants, or other derivative securities for Ramji Shiven in the data provided with this filing.

What does the transaction summary indicate in the Cellebrite (CLBT) Form 3 for Ramji Shiven?

The transaction summary shows buyCount, sellCount, acquireCount, disposeCount, and otherCount all as zero. It also reports netBuySellShares of zero and a neutral netBuySellDirection, indicating no recorded transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/07/2026 - 10:31 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Ramji Shiven

(Last) (First) (Middle)

94 SHLOMO SHMELZER ROAD

(Street)

PETAH TIKVA 4970602

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/04/2026

3. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President Products & Tech

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

No securities are beneficially owned.

	/s/ Shiven Ramji	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)